Orientation in AD Patients: PET-MR Study

UnknownOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2020

Conditions
Alzheimer DiseaseMild Cognitive Impairment
Interventions
DEVICE

"Siemens Biograph mMR PET-MR (3T)"

Standardly used Magnetic resonance imaging (MRI) protocols, including resting state fMRI, task fMRI, T1 weighted imaging. In addition Patients will receive an intravenous injection of 2-5mCi of 18F-FDG prior to PET MRI.

Sponsors
All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

lead

Assuta Medical Center

OTHER

NCT03030365 - Orientation in AD Patients: PET-MR Study | Biotech Hunter | Biotech Hunter